709 related articles for article (PubMed ID: 18177922)
41. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease.
Whelton A
Am J Cardiol; 2006 May; 97(9A):3-9. PubMed ID: 16675316
[TBL] [Abstract][Full Text] [Related]
42. Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.
Lehmann FS; Beglinger C
Curr Top Med Chem; 2005; 5(5):449-64. PubMed ID: 15974940
[TBL] [Abstract][Full Text] [Related]
43. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
Lazzaroni M; Battocchia A; Bianchi Porro G
Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
[TBL] [Abstract][Full Text] [Related]
44. Coxibs: Evolving role in pain management.
Katz N
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
[TBL] [Abstract][Full Text] [Related]
45. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
Hermann M; Ruschitzka F
Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
[TBL] [Abstract][Full Text] [Related]
46. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.
Solomon DH; Glynn RJ; Rothman KJ; Schneeweiss S; Setoguchi S; Mogun H; Avorn J; Stürmer T
Arthritis Rheum; 2008 Aug; 59(8):1097-104. PubMed ID: 18668605
[TBL] [Abstract][Full Text] [Related]
47. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor.
Mukherjee D
Thromb Haemost; 2006 Oct; 96(4):407-12. PubMed ID: 17003915
[TBL] [Abstract][Full Text] [Related]
48. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
49. Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.
Tacconelli S; Bruno A; Grande R; Ballerini P; Patrignani P
Expert Opin Drug Saf; 2017 Jul; 16(7):791-807. PubMed ID: 28569569
[TBL] [Abstract][Full Text] [Related]
50. Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
Latimer N; Lord J; Grant RL; O'Mahony R; Dickson J; Conaghan PG;
BMJ; 2009 Jul; 339():b2538. PubMed ID: 19602530
[TBL] [Abstract][Full Text] [Related]
51. Global gastrointestinal safety profile of etoricoxib and lumiracoxib.
Yuan Y; Hunt RH
Curr Pharm Des; 2007; 13(22):2237-47. PubMed ID: 17691997
[TBL] [Abstract][Full Text] [Related]
52. Anti-inflammatory agents and renal function.
Brater DC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
[TBL] [Abstract][Full Text] [Related]
53. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
54. When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis?
Lo V; Meadows SE; Saseen J
J Fam Pract; 2006 Mar; 55(3):260-2. PubMed ID: 16510063
[TBL] [Abstract][Full Text] [Related]
55. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
56. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
57. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
58. [Coronary risks with NSAID and coxibs. The end of hysteria].
Einecke D
MMW Fortschr Med; 2006 Nov; 148(48):10, 12. PubMed ID: 17615760
[No Abstract] [Full Text] [Related]
59. Coxibs: is there a benefit when compared to traditional non-selective NSAIDs in postoperative pain management?
Wickerts L; Warrén Stomberg M; Brattwall M; Jakobsson J
Minerva Anestesiol; 2011 Nov; 77(11):1084-98. PubMed ID: 21617597
[TBL] [Abstract][Full Text] [Related]
60. Cardiovascular effects of coxibs.
Caporali R; Montecucco C
Lupus; 2005; 14(9):785-8. PubMed ID: 16218488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
